Measles Workup
For suspected measles, immediately collect blood for measles-specific IgM antibody testing using a sensitive and specific assay (direct-capture IgM EIA method), and simultaneously collect nasopharyngeal swab and urine specimens for viral isolation and molecular characterization. 1
Immediate Actions
When you suspect measles (fever ≥38.3°C with maculopapular rash ≥3 days plus cough, coryza, or conjunctivitis):
- Notify public health authorities immediately - do not wait for laboratory confirmation 1
- Isolate the patient using airborne precautions
- Collect specimens during the first clinical encounter 1
Laboratory Testing Protocol
Primary Serologic Testing
Measles IgM antibody is the cornerstone of diagnosis:
- Use direct-capture IgM EIA method (most sensitive and specific) 1
- IgM may be detectable at rash onset, peaks at 10 days, disappears by 30-60 days 1
- Critical timing consideration: IgM may not be detectable in the first 72 hours after rash onset with less sensitive assays 1
If initial IgM is negative and collected <72 hours after rash onset:
- Obtain a second specimen ≥72 hours after rash onset 1
- IgM remains detectable for at least 1 month after rash onset 1
Viral Specimen Collection
Collect simultaneously with serology 1:
- Nasopharyngeal swab or mucus - for viral isolation and genotyping
- Urine specimen - for viral isolation and genotyping
- Timing is critical: Collect as close to rash onset as possible; delays reduce isolation success 1
- Contact your state/local health department for specific collection and shipping protocols 1
Alternative Serologic Method
Acute and convalescent serology (largely supplanted by IgM):
- Acute specimen: within 1-3 days of rash onset
- Convalescent specimen: 2-4 weeks later
- Requires fourfold rise in antibody titer 1
Important Caveats
False Positives
As measles becomes rare, false-positive IgM results increase 1. Parvovirus infection (fifth disease) can cause false-positive measles IgM 1.
When to confirm positive IgM:
- Patient has no identified source of infection AND
- No epidemiologic linkage to confirmed case
- Use confirmatory testing with direct-capture IgM EIA method 1
False Negatives
- Specimen collected too early (<72 hours after rash onset) 1
- Immunocompromised patients may not mount typical antibody response
- Reinfection cases rarely produce detectable IgM 1
Cross-Testing
If measles IgM is negative, test for rubella IgM in patients with febrile rash illness 1
Laboratory Confirmation Criteria
A case is laboratory-confirmed by any of the following 1:
- Positive measles IgM antibody, OR
- Significant rise in measles antibody (any standard assay), OR
- Isolation of measles virus from clinical specimen
Clinical Context
The clinical case definition requires 1:
- Generalized rash ≥3 days
- Temperature ≥38.3°C (≥101°F)
- At least one: cough, coryza, or conjunctivitis
However, vaccinated individuals may have milder or atypical presentations 2, so maintain high clinical suspicion even with incomplete symptomatology.
Workflow Summary
- Suspect measles → Notify public health immediately
- First encounter: Draw blood for IgM + collect nasopharyngeal swab + collect urine
- If IgM negative and <72 hours post-rash: Repeat IgM ≥72 hours after rash onset
- If IgM positive without epidemiologic link: Consider confirmatory testing
- If measles IgM negative: Test for rubella
- Do not delay outbreak control measures while awaiting results 1